Search Results for 'formulation'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Breaking News | Collaborations & Alliances | Drug Development | Formulation Development
Lumen Bioscience, Novo Nordisk Enter Metabolic Research Pact
To explore Lumen's drug development and manufacturing platform to deliver oral biologics for cardiometabolic disease.06.16.21
-
Capsules | Formulation Development
Formulation of Aqueous Core Poly(lactic acid) Microcapsules
This white paper demonstrates how single-step encapsulation of a water core can be achieved using Adare Pharma Solutions' Stratμm technology.
-
Formulation Development | Promotions & Moves
Adare Pharma Expands Executive Leadership Team
Key additions aim to further advance Adare’s position as a technology driven CDMO solving unique formulation challenges.Kristin Brooks 05.28.21
-
APIs | Cytotoxics and High Potency Manufacturing | Formulation Development | Process Development
Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion
Efficient processing and production technology for solid molecular dispersion, HME can provide sustained, modified and targeted drug delivery.Ameya Deshpande, Formulation Scientist, Avomeen 05.25.21
-
Breaking News | Collaborations & Alliances | Drug Development
Arecor, Lilly Sign Formulation Study Partnership
Arecor will use its proprietary formulation technology platform to develop a differentiated, thermostable formulation of one of Lilly’s proprietary products.Charles Sternberg, Assistant Editor 05.20.21
-
Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Recro, Astex Enter Drug Development Alliance
Expands partnership for oral solid dose drug product services.Kristin Brooks 05.18.21
-
Breaking News | Facilities | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
MedPharm Expands Formulation Development Labs in the UK
Announces refurbishment of its 15,000 sq. ft facility in Surrey, UK.Tim Wright, Editor, Contract Pharma 05.17.21
-
APIs | Capsules | Formulation Development
How to Achieve Precise and Flexible Dosing with Multiparticulates
Multiparticulate systems have several advantages over conventional tablet or capsule formulations. Download this whitepaper to learn more.
-
Formulation Development
Melt Extrusion and How Helps Advance New Medicines
Bernd Liepold, Ph.D. of AbbVie explains melt extrusion and how it works in the formulation of new medicines.Videos
-
Breaking News | Collaborations & Alliances | Drug Development | Formulation Development
Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
To explore synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms.Kristin Brooks 04.22.21
-
Analytical Services | Biologics, Proteins, Vaccines | Drug Development | Microbiology
Vetter Development Service
With Vetter, you have a partner you can trust to support you throughout drug product development, clinical manufacturing and regulatory approval.
-
Analytical Services | APIs | cGMP Manufacture | Excipients | Formulation Development | QA/QC | R&D | Solid Dosage/Semi-solids
Enteris BioPharma: Custom Solutions – From Bench to Market
CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.
-
Clinical Trial Materials | Drug Development | Formulation Development
On-Demand Webinar: Accelerated Timelines for Clinical Supply Manufacture
Watch this on-demand webinar to gain a deeper understanding of the value of adaptive processes at this critical early stage of drug development.
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News
Piramal Pharma Solutions, Plus Therapeutics Ink MSA
Piramal to perform services related to the development, manufacture, and supply of Plus Therapeutics’ RNL-Liposome Intermediate Drug Product.Kristin Brooks 03.24.21
-
Breaking News | Formulation Development | Industry News
Cybin to Leverage Catalent’s Zydis for Psychiatric Drug
To apply Zydis orally disintegrating tablet (ODT) technology for delivery of Cybin’s potential therapy for treatment-resistant psychiatric disorders.Kristin Brooks 03.22.21
-
Breaking News | Formulation Development | Industry News
Rentschler, Leukocare Extend Service Offering with U.S. Site
Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.Kristin Brooks 03.22.21
-
Drug Delivery | Formulation Development
On Demand Webinar - Formulation Strategies for Poorly Soluble Molecules
Pharmaceutics and Biopharmaceutics Considerations - Now Available to Watch On Demand
-
APIs | Formulation Development
Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions
Travis Webb, Formulation Scientist at CoreRx, will discuss the use of in vitro flux and permeability as a tool in formulation dev in this March 30 webinar.02.24.21
-
APIs | Drug Delivery
Screening Permeability as a Tool in Formulation Selection
Improving bioavailability can be crucial to creating a dosage form that is easy to use and meets requirements for patient compliance.
-
APIs | Breaking News | Formulation Development | Industry News
Tris Pharma, Athena Bioscience Enter Exclusive License Agreement
Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.Kristin Brooks 02.22.21
-
-
Breaking News | Formulation Development | Industry News | Promotions & Moves
Novartis Vet Joins CDMO Sai Life Sciences
Mahavir Prashad named as vice president of early phase process development.Tim Wright, Editor, Contract Pharma 02.17.21
-
APIs | Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Lonza Expands Solid Small Molecule Services
To encompass all aspects of solid form screening and characterization of small molecule APIs.Kristin Brooks 02.16.21
-
Breaking News | Formulation Development | Industry News | Methods Development
Adare Pharma Solutions Opens New Small-Scale Lab
Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.Kristin Brooks 01.26.21
-
Formulation Development
Coating Place Wurster Fluid Bed Process Scaling
With a 45-year history of involvement in formulation dev and application, this design strategy lends significant ease and predictability to process scale-up.
-
Breaking News | Formulation Development | Industry News
Hovione Launches ASD-HIPROS
Advanced tool designed to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying.Contract Pharma Staff 01.12.21
-
Formulation Development
Syngene supports both development and manufacturing of Drug Products from early to late stage.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Parenterals
Irisys Receives NIH Contract for the Formulation of Drinabant
Seeks to develop a drug for treatment of acute cannabinoid overdose.Contract Pharma Staff 01.11.21
-
Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement
Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.Contract Pharma Staff 01.04.21
-
-
Formulation Development
Formulation of Monodisperse Controlled-Release Quetiapine Microspheres
Adare’s Optimμm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time.
-
Breaking News | Drug Development | Formulation Development | Industry News
Vectura, Kinaset Partner to Develop Asthma Treatment
Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.Contract Pharma Staff 11.30.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
Lonza Expands Development, Mfg. Capabilities at Bend Site
Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.Contract Pharma Staff 11.30.20
-
Formulation Development
**ADVERTORIAL** Advanced Formulation Development by Design in the Context of Holistic Drug Production
A strong trend in drug substance and drug product biomanufacturing, as is for formulation, is that of increasing therapeutic complexity.Latika Bhonsle-Deeng, Rentschler Biopharma SE, and Konstantin Petropoulos, LEUKOCARE AG 10.14.20
-
Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
Cambrex Completes Edinburgh Expansion
Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.Contract Pharma Staff 10.12.20
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
Catalent Launches OneXpress Solution
Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.Contract Pharma Staff 10.01.20
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development
Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals
Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.Contract Pharma Staff 09.30.20
-
APIs | Formulation Development
Premature Release from Wurster Fluid Bed Enteric Coatings
The Wurster (bottom spray) fluid bed coating process provides an optimal means to apply enteric coatings on API or API containing particles.
-
APIs | Formulation Development
Expanding Solutions for Challenging APIs Through Coacervation
Download Adare Pharma Solutions' whitepaper to learn how the coacervation method can help solve your formulation challenges.
-
APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Excipients | Formulation Development | Industry News
Piramal to Deliver Integrated Services to Epirium
Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.Contract Pharma Staff 08.27.20
-
Breaking News | Collaborations & Alliances | Formulation Development
TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics
Will develop dry powder forms of niclosamide as a potential COVID-19 treatment.Contract Pharma Staff 08.17.20
-
Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax
Dalton to provide formulation and fill/finish of VIDO-InterVac’s COVID-19 vaccine to be used in early phase clinical trials.Contract Pharma Staff 07.28.20
-
Breaking News | Promotions & Moves
Avomeen Appoints Formulation, Manufacturing Head
Hashim Ahmed brings more than 25 years of experience from the biopharmaceutical and CDMO industries.Contract Pharma Staff 07.16.20
-
Breaking News | Drug Development | Formulation Development | Industry News | Laboratory Testing | Methods Development
MilliporeSigma Opens M Lab Collaboration Center in Shanghai
Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.Contract Pharma Staff 07.10.20
-
Breaking News | Collaborations & Alliances | Formulation Development
Vectura Earns $5M Novartis Milestone for Enerzair Breezhaler
Enerzair Breezhaler uses Vectura’s formulation IP, and is a first-in-class fixed-dose combination maintenance treatment for uncontrolled asthma.Contract Pharma Staff 07.07.20
-
Free Webinar: Developing an Oral Modified Release (MR) Formulation
Challenges and Considerations for Achieving Success
-
Formulation Development | Industry News
SeraNovo, Carna Biosciences Enter Second License Agreement
To develop an oral formulation of a new active ingredient with enhanced bioavailability.Contract Pharma Staff 05.26.20
-
Formulation Development | Industry News | Trials & Filings
Triphase, Catalent Announce Interim TRPH-222 Results in NHL
TRPH-222 leverages Catalent’s SMARTag platform to provide optimized site-specific protein-modification and linker technologies.Contract Pharma Staff 05.19.20
-
-
